Source: DGNews  |  Posted 9 years ago

By Charlene Laino

SAN ANTONIO, TX -- December 13, 2002 -- The nonsteroidal aromatase inhibitor letrozole is significantly superior to tamoxifen as first-line treatment of metastatic breast cancer regardless of whether one or both hormone receptors are positive or both are unknown, a new study suggests.

Alain Monnier, MD, Head of Medical Oncology and Radiotherapy at the Centre Hospitalier Andr